FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace BPC 157 Erectile Dysfunction Study: What the Evidence Actually Shows The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA moves toward easing restrictions on certain peptides BioPharma Dive